“I am pleased to offer my medical and scientific expertise in the development of a promising new approach for the early diagnosis and treatment of cancer.
The mode of action of B-OT as a transketolase inhibitor and its therapeutic spectrum needs to be further researched quickly. If the initial positive results are confirmed, an important drug could emerge here.”

“A fundamental requirement for cancer growth is the increased energy supply to tumor cells. Tumor cells, regardless of their origin in the body, differ from healthy cells primarily in their enhanced uptake of sugar. Therefore, blocking the heightened sugar metabolism and thus the energy supply to tumor cells using B-OT could represent a therapeutic approach applicable to all types of cancer and potentially improve recovery prospects. Further studies on this new therapeutic approach are necessary, as they could lead to entirely new treatment strategies for cancer.”